Vimarsana
Biggest News Aggregation in the World

Page 5 - Adaptive Research News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Adaptive Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Adaptive Research Today - Breaking & Trending Today

Kintara Therapeutics Awarded $2.0 Million National Institutes of Health SBIR Grant to Support the Clinical Development of REM-001 - Vimarsana News

Kintara Therapeutics Awarded $2.0 Million National Institutes of Health SBIR Grant to Support the Clinical Development of REM-001

/PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid...

Bioinformatics: Partnering Deals & Agreements 2016-2023 - Understand Historical Key Deal Terms and Undertake Due Diligence to Assess Suitability of Your Proposed Deal - Vimarsana News

Bioinformatics: Partnering Deals & Agreements 2016-2023 - Understand Historical Key Deal Terms and Undertake Due Diligence to Assess Suitability of Your Proposed Deal

/PRNewswire/ -- The "Global Bioinformatics Partnering Terms and Agreements 2016 to 2023" report has been added to ResearchAndMarkets.com's offering. The Global...

Kintara Therapeutics to Participate in the Maxim Group Virtual Healthcare Conference - Vimarsana News

Kintara Therapeutics to Participate in the Maxim Group Virtual Healthcare Conference

SAN DIEGO, June 16, 2023 /PRNewswire/ -- Kintara Therapeutics, Inc.  , a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced that its... | June 16, 2023

KAZIA CEO, DR. JOHN FRIEND TO PARTICIPATE IN WHITE HOUSE CANCER MOONSHOT - Vimarsana News

KAZIA CEO, DR. JOHN FRIEND TO PARTICIPATE IN WHITE HOUSE CANCER MOONSHOT

/PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, has been invited to the White House to...

Kintara Therapeutics to Commemorate National Brain Tumor Awareness Month with Ringing the Bell at Nasdaq Closing Along with Global Coalition for Adaptive Research and the National Brain Tumor Society - Vimarsana News

Kintara Therapeutics to Commemorate National Brain Tumor Awareness Month with Ringing the Bell at Nasdaq Closing Along with Global Coalition for Adaptive Research and the National Brain Tumor Society

/PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid...